The developed prediction model for HE in TBC patients demonstrates excellent discrimination and calibration, providing quantitative evidence for individualized monitoring and treatment strategies that may improve patient outcomes. This scoring system is simple, practical, and holds promising clinical application potential.
Liu et al. (Thu,) studied this question.